Mohammad Alyamani

973 total citations
19 papers, 709 citations indexed

About

Mohammad Alyamani is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Mohammad Alyamani has authored 19 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Genetics. Recurrent topics in Mohammad Alyamani's work include Prostate Cancer Treatment and Research (16 papers), Hormonal and reproductive studies (13 papers) and Estrogen and related hormone effects (5 papers). Mohammad Alyamani is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Hormonal and reproductive studies (13 papers) and Estrogen and related hormone effects (5 papers). Mohammad Alyamani collaborates with scholars based in United States, Pakistan and Spain. Mohammad Alyamani's co-authors include Nima Sharifi, Zhenfei Li, Richard J. Auchus, Sunil Upadhyay, Jianneng Li, Jorge A. García, Mary-Ellen Taplin, Jiayan Liu, Robert Dreicer and Andrew C. Bishop and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Mohammad Alyamani

17 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Alyamani United States 13 522 317 219 183 142 19 709
Kriti Singh Canada 13 371 0.7× 143 0.5× 323 1.5× 245 1.3× 145 1.0× 38 695
Riikka Oksala Finland 9 365 0.7× 169 0.5× 136 0.6× 86 0.5× 127 0.9× 20 492
Stephen Balk United States 6 720 1.4× 295 0.9× 458 2.1× 196 1.1× 436 3.1× 8 1.0k
Nhin Lu 3 402 0.8× 114 0.4× 191 0.9× 120 0.7× 180 1.3× 6 502
William E. Bingman United States 10 360 0.7× 172 0.5× 412 1.9× 325 1.8× 137 1.0× 11 710
J. Bolt Netherlands 11 291 0.6× 237 0.7× 216 1.0× 205 1.1× 41 0.3× 13 513
Barbara Comuzzi Austria 11 324 0.6× 86 0.3× 255 1.2× 152 0.8× 130 0.9× 13 515
Adam Schayowitz United States 8 203 0.4× 95 0.3× 165 0.8× 184 1.0× 92 0.6× 10 394
Andrew T. Hnat United States 8 234 0.4× 169 0.5× 297 1.4× 202 1.1× 33 0.2× 10 488
Kate Frewin Canada 8 188 0.4× 99 0.3× 222 1.0× 149 0.8× 59 0.4× 10 416

Countries citing papers authored by Mohammad Alyamani

Since Specialization
Citations

This map shows the geographic impact of Mohammad Alyamani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Alyamani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Alyamani more than expected).

Fields of papers citing papers by Mohammad Alyamani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Alyamani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Alyamani. The network helps show where Mohammad Alyamani may publish in the future.

Co-authorship network of co-authors of Mohammad Alyamani

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Alyamani. A scholar is included among the top collaborators of Mohammad Alyamani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Alyamani. Mohammad Alyamani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhu, Ziqi, Yoon-Mi Chung, Mohammad Alyamani, et al.. (2025). A bypass gateway from cholesterol to sex steroid biosynthesis circumnavigates CYP17A1. Nature Communications. 16(1). 10611–10611.
2.
Cui, Di, Jianneng Li, Ziqi Zhu, et al.. (2023). Cancer-associated fibroblast-secreted glucosamine alters the androgen biosynthesis program in prostate cancer via HSD3B1 upregulation. Journal of Clinical Investigation. 133(7). 25 indexed citations
3.
Alyamani, Mohammad, et al.. (2023). Approaches to assessing 3β-hydroxysteroid dehydrogenase-1. Methods in enzymology on CD-ROM/Methods in enzymology. 689. 89–119. 4 indexed citations
4.
Alyamani, Mohammad, Patrick Michael, Lewis J. Thomas, et al.. (2023). Elevated periprostatic venous testosterone correlates with prostate cancer progression after radical prostatectomy. Journal of Clinical Investigation. 133(17). 1 indexed citations
5.
Goins, Christopher M., Mohammad Alyamani, Yoon‐Mi Chung, et al.. (2023). BMX controls 3βHSD1 and sex steroid biosynthesis in cancer. Journal of Clinical Investigation. 133(2). 19 indexed citations
6.
Li, Jianneng, Mohammad Alyamani, Navin Sabharwal, et al.. (2021). Hexose-6-phosphate dehydrogenase blockade reverses prostate cancer drug resistance in xenograft models by glucocorticoid inactivation. Science Translational Medicine. 13(595). 17 indexed citations
7.
Alyamani, Mohammad, Sarah Taylor, Michael Berk, et al.. (2020). Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure. Annals of Oncology. 31(3). 369–376. 17 indexed citations
8.
McManus, Jeffrey M., et al.. (2019). Rapid and structure-specific cellular uptake of selected steroids. PLoS ONE. 14(10). e0224081–e0224081. 18 indexed citations
9.
Blanchet, Benoı̂t, Mohammad Alyamani, Lisa Golmard, et al.. (2018). A PK/PD study of Delta-4 abiraterone metabolite in metastatic castration-resistant prostate cancer patients. Pharmacological Research. 136. 56–61. 11 indexed citations
10.
Alyamani, Mohammad, Hamid Emamekhoo, Sunho Park, et al.. (2018). HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer. Journal of Clinical Investigation. 128(8). 3333–3340. 42 indexed citations
11.
Zhang, Ao, et al.. (2018). AR Signaling in Prostate Cancer Regulates a Feed-Forward Mechanism of Androgen Synthesis by Way of HSD3B1 Upregulation. Endocrinology. 159(8). 2884–2890. 16 indexed citations
12.
Emamekhoo, Hamid, Mohammad Alyamani, Sunho Park, et al.. (2018). HSD3B1 genotype and abiraterone (Abi) metabolites in patients (pts) with prostate cancer (PCa).. Journal of Clinical Oncology. 36(6_suppl). 325–325. 1 indexed citations
13.
Mostaghel, Elahe A., Eunpi Cho, Ailin Zhang, et al.. (2017). Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer. Clinical Cancer Research. 23(16). 4592–4601. 31 indexed citations
14.
Alyamani, Mohammad, Zhenfei Li, Michael Berk, et al.. (2017). Steroidogenic Metabolism of Galeterone Reveals a Diversity of Biochemical Activities. Cell chemical biology. 24(7). 825–832.e6. 37 indexed citations
15.
Li, Jianneng, Mohammad Alyamani, Ao Zhang, et al.. (2017). Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer. eLife. 6. 98 indexed citations
16.
Li, Zhenfei, Mohammad Alyamani, Jianneng Li, Mary‐Ellen Taplin, & Nima Sharifi. (2017). Abstract A17: Abiraterone metabolism and a novel therapeutic strategy for castration resistant prostate cancer. Clinical Cancer Research. 23(1_Supplement). A17–A17. 1 indexed citations
17.
Alyamani, Mohammad, Zhenfei Li, Sunil Upadhyay, et al.. (2016). Development and validation of a novel LC–MS/MS method for simultaneous determination of abiraterone and its seven steroidal metabolites in human serum: Innovation in separation of diastereoisomers without use of a chiral column. The Journal of Steroid Biochemistry and Molecular Biology. 172. 231–239. 27 indexed citations
18.
Li, Zhenfei, Mohammad Alyamani, Jianneng Li, et al.. (2016). Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy. Nature. 533(7604). 547–551. 139 indexed citations
19.
Li, Zhenfei, Andrew C. Bishop, Mohammad Alyamani, et al.. (2015). Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer. Nature. 523(7560). 347–351. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kriti Singh Breakdown of academic impact, for papers by Riikka Oksala Breakdown of academic impact, for papers by Stephen Balk Breakdown of academic impact, for papers by Nhin Lu Breakdown of academic impact, for papers by William E. Bingman Breakdown of academic impact, for papers by J. Bolt Breakdown of academic impact, for papers by Barbara Comuzzi Breakdown of academic impact, for papers by Adam Schayowitz Breakdown of academic impact, for papers by Andrew T. Hnat Breakdown of academic impact, for papers by Kate Frewin
Rankless by CCL
2026